Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neuro-immunology
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
Related Questions
When do you suspect an autoimmune encephalitis in a child or adolescent with new-onset psychosis?
How do you counsel B cell-depleted multiple sclerosis patients on the benefits of regular COVID-19 vaccinations?
In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?
When do you consider cannabidiol for treatment of epilepsy?
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
What is your approach to treatment when there is a multiple sclerosis reactivation while on natalizumab?
How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
How do you determine if generic vs brand formulation of a DMT is the probable cause of worsening multiple sclerosis disease activity?
What are your vaccine recommendations while patients are on biologics?
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
